Suppr超能文献

原卟啉原和粪卟啉原对人淋巴母细胞及纯化的胆色素原脱氨酶的变构抑制作用。杂色卟啉症急性发作的一种可能机制。

Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.

作者信息

Meissner P, Adams P, Kirsch R

机构信息

MRC/UCT Liver Research Centre, Department of Medicine, Old Groote Schuur Hospital, Observatory, South Africa.

出版信息

J Clin Invest. 1993 Apr;91(4):1436-44. doi: 10.1172/JCI116348.

Abstract

Variegate porphyria (VP) is characterized by photocutaneous lesions and acute neuropsychiatric attacks. Decreased protoporphyrinogen oxidase activity results in accumulation of protoporphyrin (ogen) IX and coproporphyrin (ogen) III. During acute attacks delta-aminolevulinic acid and porphobilinogen also increase, suggesting that porphobilinogen deaminase (PBG-D) may be rate limiting. We have examined the effects of porphyrinogens accumulating in VP on PBG-D activity in Epstein-Barr virus-transformed lymphoblast sonicates from 12 VP and 12 control subjects. Protoporphyrinogen oxidase activity was decreased and protoporphyrin increased in VP lymphoblasts. PBG-D in control lymphoblasts obeyed Michaelis-Menten kinetics (Vmax 28.7 +/- 1.8 pmol/mg per h, Hill coefficient 0.83 +/- 0.07). VP sonicates yielded sigmoidal substrate-velocity curves that did not obey Michaelis-Menten kinetics. Vmax was decreased (21.2 +/- 2.0 pmol/mg per h) and the Hill coefficient was 1.78 +/- 0.17. Addition of protoporphyrinogen IX and coproporphyrinogen III to control sonicates yielded sigmoidal PBG-D substrate-velocity curves and decreased PBG-D Vmax. Addition of porphyrins or uroporphyrinogen III did not affect PBG-D activity. Removal of endogenous porphyrin (ogens) from VP sonicates restored normal PBG-D kinetics. Purified human erythrocyte PBG-D obeyed Michaelis-Menten kinetics (Vmax 249 +/- 36 nmol/mg per h, Km 8.9 +/- 1.5 microM, Hill coefficient 0.93 +/- 0.14). Addition of protoporphyrinogen yielded a sigmoidal curve with decreased Vmax. The Hill coefficient approached 4. These findings provide a rational explanation for the increased delta-aminolevulinic acid and porphobilinogen during acute attacks of VP.

摘要

混合型卟啉病(VP)的特征是光皮肤损伤和急性神经精神发作。原卟啉原氧化酶活性降低导致原卟啉(原)IX和粪卟啉(原)III积累。在急性发作期间,δ-氨基乙酰丙酸和卟胆原也会增加,这表明卟胆原脱氨酶(PBG-D)可能是限速酶。我们研究了VP中积累的卟啉原对12名VP患者和12名对照者的爱泼斯坦-巴尔病毒转化淋巴细胞超声裂解物中PBG-D活性的影响。VP淋巴细胞中原卟啉原氧化酶活性降低,原卟啉增加。对照淋巴细胞中的PBG-D符合米氏动力学(Vmax为28.7±1.8 pmol/mg每小时,希尔系数为0.83±0.07)。VP超声裂解物产生的S形底物-速度曲线不符合米氏动力学。Vmax降低(21.2±2.0 pmol/mg每小时),希尔系数为1.78±0.17。向对照超声裂解物中添加原卟啉原IX和粪卟啉原III产生S形PBG-D底物-速度曲线,并降低PBG-D Vmax。添加卟啉或尿卟啉原III不影响PBG-D活性。从VP超声裂解物中去除内源性卟啉(原)可恢复正常的PBG-D动力学。纯化的人红细胞PBG-D符合米氏动力学(Vmax为249±36 nmol/mg每小时,Km为8.9±1.5 μM,希尔系数为0.93±0.14)。添加原卟啉原产生Vmax降低的S形曲线。希尔系数接近4。这些发现为VP急性发作期间δ-氨基乙酰丙酸和卟胆原增加提供了合理的解释。

相似文献

2
Protoporphyrinogen oxidase and porphobilinogen deaminase in variegate porphyria.
Eur J Clin Invest. 1986 Jun;16(3):257-61. doi: 10.1111/j.1365-2362.1986.tb01339.x.
4
Studies on uroporphyrinogen biosynthesis in pig liver.猪肝中尿卟啉原生物合成的研究。
Z Naturforsch C J Biosci. 1991 Nov-Dec;46(11-12):1101-8. doi: 10.1515/znc-1991-11-1228.
6
Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity.
Acta Derm Venereol. 2001 Oct-Nov;81(5):356-9. doi: 10.1080/000155501317140098.
8
Alcohol and porphyrin metabolism.酒精与卟啉代谢
Alcohol Alcohol. 2000 Mar-Apr;35(2):109-25. doi: 10.1093/alcalc/35.2.109.

引用本文的文献

2
Laboratory Diagnosis of Porphyria.卟啉病的实验室诊断
Diagnostics (Basel). 2021 Jul 26;11(8):1343. doi: 10.3390/diagnostics11081343.
3
Unexpected presentation of acute porphyria.急性卟啉病的意外表现。
BMJ Case Rep. 2021 Jun 29;14(6):e241580. doi: 10.1136/bcr-2021-241580.
5
The acute hepatic porphyrias.急性肝卟啉病
Transl Gastroenterol Hepatol. 2021 Apr 5;6:24. doi: 10.21037/tgh-2020-01. eCollection 2021.
6
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria.急性间歇性卟啉症的药物伴侣治疗。
Mol Ther. 2020 Feb 5;28(2):677-689. doi: 10.1016/j.ymthe.2019.11.010. Epub 2019 Dec 4.
7
Acute hepatic porphyrias: Current diagnosis & management.急性肝卟啉症:当前的诊断与管理。
Mol Genet Metab. 2019 Nov;128(3):219-227. doi: 10.1016/j.ymgme.2019.07.002. Epub 2019 Jul 5.
8
[Porphyrias-what is verified?].[卟啉病——已证实的是什么?]
Internist (Berl). 2018 Dec;59(12):1239-1248. doi: 10.1007/s00108-018-0509-z.
10
Dominant versus recessive: molecular mechanisms in metabolic disease.显性与隐性:代谢性疾病的分子机制
J Inherit Metab Dis. 2008 Oct;31(5):599-618. doi: 10.1007/s10545-008-1016-5. Epub 2008 Oct 21.

本文引用的文献

8
Porphyria cutanea tarda.迟发性皮肤卟啉病
Semin Liver Dis. 1982 May;2(2):132-42. doi: 10.1055/s-2008-1040703.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验